Deguelin targets multiple oncogenic signaling pathways to combat human malignancies.
Tuli HS, Mittal S, Loka M, Aggarwal V, Aggarwal D, Masurkar A, Kaur G, Varol M, Sak K, Kumar M, Sethi G, Bishayee A.
Tuli HS, et al. Among authors: mittal s.
Pharmacol Res. 2021 Apr;166:105487. doi: 10.1016/j.phrs.2021.105487. Epub 2021 Feb 11.
Pharmacol Res. 2021.
PMID: 33581287
Review.